NGF, released by cancer cells, tumor-associated immune cells, and fibroblasts, stimulates the sensitive sensory nerves by interacting with transient receptor potential cation channel subfamily V member 1 (TRPV1) (Silverman et al., 2021). The gene discussed is NGF; the disease is neoplasm.